Small Molecule Drug Discovery Market Research Reveals Path To $117.05 Billion By 2030

The small molecule drug discovery sector is evolving quickly, driven by scientific breakthroughs and strategic collaborations. As the industry advances, it is poised to expand significantly in the coming years. Let's explore the current market size, key growth drivers, prominent players, emerging trends, and major segments shaping this important field.

Projected Growth Trajectory of the Small Molecule Drug Discovery Market
The market for small molecule drug discovery has been expanding swiftly and is forecasted to increase from $67.94 billion in 2025 to $75.56 billion in 2026, representing a compound annual growth rate (CAGR) of 11.2%. This growth during the past years has primarily been fueled by rising research and development investments from pharmaceutical firms, an increase in chronic disease cases, continual advancements in molecular biology, heightened demand for affordable therapies, and the rise of contract research organizations (CROs).

Download a free sample of the small molecule drug discovery market report:
https://thebusinessresearchcompany.com/sample_request?id=89471392&type=smp&name=Small%20Molecule%20Drug%20Discovery%20Market%20Report%202026&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR

Looking ahead, the market is expected to maintain its rapid momentum, reaching $117.05 billion by 2030 with an estimated CAGR of 11.6%. Key factors supporting this forecast include the integration of artificial intelligence and machine learning in drug discovery processes, the broadening scope of precision medicine, stronger collaborations between biotechnology and pharmaceutical companies, the adoption of automated high-throughput screening technologies, and a growing focus on addressing rare and complex disease conditions. Among the prominent trends anticipated to influence the market are increased use of high-throughput screening, advancements in combinatorial chemistry, application of nanotechnology in drug design, development of personalized medicine, and improvements in target validation and lead optimization methodologies.

Prominent Players Driving the Small Molecule Drug Discovery Market
Several leading companies play significant roles in this market, including Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION Therapeutics, Allarity Therapeutics, Cyteir Therapeutics, and BigHat Biosciences.

View the full small molecule drug discovery market report:
https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR

Significant Acquisition Strengthening Neuroscience Portfolio
In April 2025, Johnson & Johnson, a US-based biopharmaceutical leader known for prescription pharmaceuticals, medical devices, and consumer health products, acquired Intra Cellular Therapies, Inc. Although the purchase amount was undisclosed, this move is strategically aimed at enhancing Johnson & Johnson's neuroscience portfolio. The acquisition is expected to boost its capabilities in small-molecule central nervous system (CNS) therapeutics and accelerate advances in treatments for mental health and neurodegenerative disorders. Intra Cellular Therapies, Inc., also US-based, specializes in developing small-molecule CNS drugs targeting psychiatric and neurodegenerative diseases.

Collaborations Powering Innovation in Small Molecule Drug Discovery
Partnerships are becoming a major trend as companies join forces to increase market reach and foster innovation. For example, in November 2023, Evommune, a US nonprofit organization, teamed up with Accutar Biotechnology, a US biotech firm, to focus on AI-driven drug discovery aimed at chronic inflammatory diseases. This collaboration leverages Accutar's proprietary AI platform along with Evommune's expertise to identify new small molecule drug candidates, showcasing how partnerships fuel progress in this domain.

Dominant Market Segments Within Small Molecule Drug Discovery
The small molecule drug discovery market is categorized across various dimensions, including:

1) Drug Type: Small Molecule Drugs and Biologic Drugs
2) Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, and Others
3) Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, and Others
4) Process or Phase: Target Identification or Validation, Hit Generation and Selection, Lead Identification, Lead Optimization
5) End-User: Pharmaceutical Companies, Contract Research Organizations, and Others

Further subcategories include:
- Small Molecule Drugs: Generic and Novel Small Molecule Drugs
- Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell and Gene Therapies

These segments provide a detailed framework to understand the landscape and key opportunities within the small molecule drug discovery market.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.